| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/27/2005 | US20050020494 Modified human growth hormone |
| 01/27/2005 | US20050020482 Methods for modulating gap junctions |
| 01/27/2005 | US20050019953 Biosensing apparatus for monitoring concentrations of preferential compounds in biological fluids |
| 01/27/2005 | US20050019915 Oligonucleotides for use in controlling expression of gene coding polypeptide associated with catalyzing the dismutation of superoxide to hydrogen peroxide; antiproliferative agents; antitumor agents; gene expression inhibition |
| 01/27/2005 | US20050019912 Method od cell culture |
| 01/27/2005 | US20050019893 Sequences for detection and identification of methicillin-resistant staphyloccocus |
| 01/27/2005 | US20050019892 Screening process for antibacterial agents |
| 01/27/2005 | US20050019889 Human osteoclast derived cathepsin |
| 01/27/2005 | US20050019884 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
| 01/27/2005 | US20050019875 Sample processing device and method |
| 01/27/2005 | US20050019872 PC-LECTIN protein; vaccines and diagnostic marker for prostate cancer |
| 01/27/2005 | US20050019869 Chimeric neuropeptide Y receptors |
| 01/27/2005 | US20050019866 Nucleotide sequences coding membrane protein for use in diagnosis, detection, prevention and/or treatment of cell proliferative disorders |
| 01/27/2005 | US20050019858 Novel human cytokine/steroid receptor protein |
| 01/27/2005 | US20050019854 Analyzing insulin response; solid phase synthesis; for treatment of prediabetes, hyperinsulinemia, and type II diabetes; kits |
| 01/27/2005 | US20050019851 Use of VLCFAE for identifying herbicidally active compounds |
| 01/27/2005 | US20050019850 Method for identifying fungicidally active compounds based on guanylate kinases |
| 01/27/2005 | US20050019849 Such as glucose oxidase, cholesterol oxidase, lactate oxidase, and/or sarcosine oxidase; luminescent dyes as transducers |
| 01/27/2005 | US20050019846 Using ornithine carbamoyltransferase (OCT) as diagnostic tool in screening for antifungal agents; fungicides and disease resistant plants |
| 01/27/2005 | US20050019845 Immunoconjugates of antibodies and cytotoxic agents (ricin, taxol); for treament of cancer and metastasis; tomography |
| 01/27/2005 | US20050019842 Analyzing the identification and the concentration of particular target analytes; biological and chemical assays, receptor binding assay; bioassay of proteins, nucleic acids, peptide nucleic acids, biological cells, microorganisms |
| 01/27/2005 | US20050019840 Non-endogenous, constitutively activated known G protein-coupled receptors |
| 01/27/2005 | US20050019839 Secretions of proteins by encapsulated cells |
| 01/27/2005 | US20050019835 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 01/27/2005 | US20050019832 IGF-1 receptor interacting proteins |
| 01/27/2005 | US20050019830 Methods of screening for TRPM5 modulators |
| 01/27/2005 | US20050019829 Generating and identifying polypeptide stability, folding and/or solubility mutants comprising; mutagenizing gene sequences, expressing in hosst cell, determine protein structure |
| 01/27/2005 | US20050019823 Using enhanced concentration of transmembrane polypeptide as diagnostic indicator of cell proliferative disorers; diagnosing cancer; antitumor agents |
| 01/27/2005 | US20050019822 Using presence of short tandem repeat sequence in promoter region of cholecystokinin gene as a diagnostic indicator of panic associated psychological/psychiatric disorders; anxiolytic agents |
| 01/27/2005 | US20050019821 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/27/2005 | US20050019818 Human TBX20 gene and uses |
| 01/27/2005 | US20050019817 Producing oligonucleotides extended by a single nucleotide base; comprising preparing single stranded nucleotide mixture, incubate with terminal transferase and labeled chain terminating agents, recovvering reaction product; generating oligonucleotide standards |
| 01/27/2005 | US20050019812 Neutral amino acid transporter and gene thereof |
| 01/27/2005 | US20050019811 Neutral amino acid transporter and gene thereof |
| 01/27/2005 | US20050019810 Nucleotide sequences coding transmembrane protein (TANGO) for use as tool in detection of modulator for prevention and treatment of inflammation and cell proliferative disorders |
| 01/27/2005 | US20050019806 Nucleic acids and polypeptides required for cell survival in the absence of Rb |
| 01/27/2005 | US20050019805 System and method for coding information on a biosensor test strip |
| 01/27/2005 | US20050019803 Array electrode |
| 01/27/2005 | US20050019800 Multicompartment apparatus which utilizes fluorescence from conductive polymers to determine sequence of preferential nucleotide sequences |
| 01/27/2005 | US20050019797 Using gene expression patterns, generated after exposure of cell to mediator protein, to elucidate gene components of preferential biological pathway; reconstructing networks of relationships between genes |
| 01/27/2005 | US20050019795 Nucleotide sequences comprising allelic variants coding protease-activated receptor 1 (PAR1) for use as tool in diagnosis, classification, prevention and treatment of heart disease |
| 01/27/2005 | US20050019794 Multilayered microfluidic apparatus for positioning protein crystal within an energy beam; high throughput assay; protein structure analysis |
| 01/27/2005 | US20050019793 Global amplification using a randomly primed composite primer |
| 01/27/2005 | US20050019792 Microfluidic device and methods of using same |
| 01/27/2005 | US20050019791 Amidation; lamination; solid phase synthesis; detecting hybridization; genotyping |
| 01/27/2005 | US20050019789 Thermostable DNA polymerase from anaerocellum thermophilum |
| 01/27/2005 | US20050019788 Genetic markers for skatole metabolism |
| 01/27/2005 | US20050019787 Apparatus and methods for analyzing and characterizing nucleic acid sequences |
| 01/27/2005 | US20050019786 Synthesizing a plurality of biopolymers at predetermined locations on the surface of a substrate; DNA hybridization and disease diagnosis |
| 01/27/2005 | US20050019785 Gene expression profiling of EGFR positive cancer |
| 01/27/2005 | US20050019784 Method and apparatus for nucleic acid sequencing and identification |
| 01/27/2005 | US20050019783 Method of determining a chemotherapeutic regimen based on glutathione-s transferase pi expression |
| 01/27/2005 | US20050019782 Diagnostic test kit for determining a predisposition for breast and ovarian cancer, materials and methods for such determination |
| 01/27/2005 | US20050019781 Using concentration of neural cell adhesion molecule as doagnostic indicator of neurodegenerative diseases |
| 01/27/2005 | US20050019779 Methods and compositions for the preparation and use of fixed-treated cell-lines and tissue in fluorescence in situ hybridization |
| 01/27/2005 | US20050019778 Sequential generation of multiple chemiluminescent signals on solid supports |
| 01/27/2005 | US20050019776 Using single-stranded oligonucleotie primer pairs as tools in multiplexed single nucleotide polymorphism (SNP) diagnostics |
| 01/27/2005 | US20050019773 Method for producing and identifying soluble protein domains |
| 01/27/2005 | US20050019772 Identifying periodontitis- or caries-associated bacterium using species specific probes; diagnosing periodontal disease |
| 01/27/2005 | US20050019771 Novel germinal center kinase proteins, compositions, and methods of use |
| 01/27/2005 | US20050019769 Obtain cells, lyse, separate cell components, resuspended in saline, subjet to enzymatic treatment, precipitate DNA, resuspend in low salt solution |
| 01/27/2005 | US20050019768 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 01/27/2005 | US20050019767 Nucleic acid compositions conferring disease resistance |
| 01/27/2005 | US20050019766 Nucleotide sequences coding iron sulfur protein (ISP-1) and or cytochrome b locus (CTB-1) protein for use as tool in detection of modulators for treatment, prevention or ameloriation of developmental, behavioral, reproductive and aging disorders |
| 01/27/2005 | US20050019765 Methods for treating disorders of the nervous and reproductive systems |
| 01/27/2005 | US20050019764 Method for analyzing t lymphocytes with the aid of t lymphocyte receptors of an organism |
| 01/27/2005 | US20050019763 Isolated polypeptide of given sequence; expression vectors, host cells, antibodies, agonists, and antagonists; use in diagnosing, treating, or preventing various disorders |
| 01/27/2005 | US20050019762 Method for quantifying cytosine methylations in genomic dna that is amplified in a complex manner |
| 01/27/2005 | US20050019760 Analysing polynucleotide sequences |
| 01/27/2005 | US20050019757 Contaminant detection apparatus |
| 01/27/2005 | US20050019756 Methods and compositions for use in diagnosing and characterizing diseases involving abnormal apoptosis |
| 01/27/2005 | US20050019752 Novel chimeric rev, tat, and nef antigens |
| 01/27/2005 | US20050019751 Contacting human scavenger receptor class B type I with polypeptide and measuring ability of test compound to inhibit binding; used in treatment and prophylaxis |
| 01/27/2005 | US20050019747 depositing monomers on a substrate, polymerizing, incubating the substrate in a cell and characterizing a predetermined cell behavior on each polymer element |
| 01/27/2005 | US20050019573 comprises biotin covalently attached to a polymer that has monosaccharide or amino acid as a constituent monomer covalently attached to a luminescent substance (cyanoisoindoles, luminols, and acridinium esters); detecting a target substance at high sensitivity |
| 01/27/2005 | US20050019486 Functionalized encapsulated fluorescent nanocrystals |
| 01/27/2005 | US20050019344 Antigens; vaccines; isolated peptide |
| 01/27/2005 | US20050019332 Laminin chains: diagnostic uses |
| 01/27/2005 | US20050019304 Novel human mage-like protein |
| 01/27/2005 | US20050019261 Using serine protease inhibitor; contacting brain tissue; analyzing in variations in protease gene expression |
| 01/27/2005 | US20050019259 Screening methods for pathogen virulence factors under low oxygen conditions |
| 01/27/2005 | US20050019251 Administering isotope labeled water to tissue; measurement; calibration |
| 01/27/2005 | DE10328394A1 Verfahren zum Aufschluss und zur Derivatisierung biologischer Proben sowie Verfahren zum bakteriellen Nachweis Procedures for digestion and derivatization of biological samples and method for bacterial detection |
| 01/27/2005 | DE10328136A1 Sensor-Element, Sensor-Array und Verfahren zum Erfassen von in einem Analyten möglicherweise enthaltenen Partikeln Sensor element, sensor array and method of detecting particles possibly contained in an analyte |
| 01/27/2005 | DE10106370B4 Oligonukleotidsonden zur Detektion von parodontopathogenen Bakterien mittels in situ-Hybridisierung Oligonucleotide probes for the detection of periodontal bacteria by means of in situ hybridization |
| 01/27/2005 | CA2534027A1 Variants of human taste receptor genes |
| 01/27/2005 | CA2533522A1 Amino acid-substituted coagulation factor v |
| 01/27/2005 | CA2533309A1 Assays for protease enzyme activity |
| 01/27/2005 | CA2533078A1 Improving production characteristics of cattle |
| 01/27/2005 | CA2532220A1 Measurement of a polynucleotide amplification reaction |
| 01/27/2005 | CA2532216A1 Oligodendrocyte precursor cells and methods of obtaining and culturing the same |
| 01/27/2005 | CA2532203A1 Method of diagnosis and treatment for asthma based on haplotype association |
| 01/27/2005 | CA2531971A1 Universal detection of binding |
| 01/27/2005 | CA2531967A1 Expression profile algorithm and test for cancer prognosis |
| 01/27/2005 | CA2531908A1 Pknb kinase and pstp phosphatase and methods of identifying inhibitory substances |
| 01/27/2005 | CA2531698A1 Method for assaying protein-protein interaction |
| 01/27/2005 | CA2531631A1 Method for assessing behavioral predisposition |
| 01/27/2005 | CA2531571A1 Genetic marker of response to atypical antipsychotics and antidepressants and methods for use thereof |
| 01/27/2005 | CA2531560A1 Hairpin-labeled probes and methods of use |
| 01/27/2005 | CA2531069A1 Inhibition of syk kinase expression |